Literature DB >> 2449988

The influence of the protease inhibitor aprotinin on tumor invasion of three cell lines in vitro.

E Prange1, W Schroyens, H Pralle.   

Abstract

The production of protease by malignant cells has been held responsible for invasion. The effect of aprotinin, a broad-spectrum protease inhibitor, on malignant invasion was examined histologically in organotypical cocultures of precultured embryonic chick heart fragments with two human melanoma cell lines and one virus-transformed fetal mouse carcass cell line. In the presence of 400 KIU/ml aprotinin, invasion was still permissive, while in the comparison with 0.1 microgram/ml vincristine, a microtubule and directional motility inhibitor and a well-documented anti-invasive agent, invasion was completely stopped. Aprotinin remained stable in the culture medium so that the presence of invasion cannot be explained by low drug concentration. It is concluded that aprotinin-sensitive proteases are not implicated in invasion in vitro in the cell types investigated, and that this in vitro technique deserves further interest for the study of protease inhibitors in the mechanism of invasion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2449988     DOI: 10.1007/bf01784841

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  17 in total

1.  Lysosomal enzyme inhibitors and antimetastatic activity in the mouse.

Authors:  T Giraldi; C Nisi; G Sava
Journal:  Eur J Cancer       Date:  1977-11       Impact factor: 9.162

2.  Regulation of plasminogen activator activity in human fibroblastic cells by fibrosarcoma cell-derived factors.

Authors:  O Saksela; M Laiho; J Keski-Oja
Journal:  Cancer Res       Date:  1985-05       Impact factor: 12.701

3.  The effect of trasylol (Trascolan "Polfa") and p-aminomethylbenzoic acid (Pamba "Germed") on the experimental metastases of transplantable melanotic melanoma in golden hamster (Mesocricetus auratus, Waterhouse)

Authors:  Z Zbytniewski; G Drewa; A Kanclerz
Journal:  Arch Geschwulstforsch       Date:  1977

4.  Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro.

Authors:  U P Thorgeirsson; L A Liotta; T Kalebic; I M Margulies; K Thomas; M Rios-Candelore; R G Russo
Journal:  J Natl Cancer Inst       Date:  1982-11       Impact factor: 13.506

5.  Isolation of a protease inhibitor from tissues resistant to tumor invasion.

Authors:  D B Rifkin; R M Crowe
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1977-12

6.  Nocodazole, a new synthetic antimitotic agent, enhances the production of plasminogen activator by cells in culture.

Authors:  F De Clerck; M De Brabander
Journal:  Thromb Res       Date:  1977-12       Impact factor: 3.944

7.  Non-infectious intracisternal A-type particles in a sarcoma-positive, leukemia-negative mouse cell line transformed by murine sarcoma virus (MSV).

Authors:  A Billiau; H Sobis; H Eyssen; H Van den Berghe
Journal:  Arch Gesamte Virusforsch       Date:  1973

8.  Vinblastine, Vincristine and Vindesine: anti-invasive effect on MO4 mouse fibrosarcoma cells in vitro.

Authors:  M M Mareel; G A Storme; G K De Bruyne; R M Van Cauwenberge
Journal:  Eur J Cancer Clin Oncol       Date:  1982-02

9.  Inhibition of malignant cell invasion in vitro by a proteinase inhibitor.

Authors:  A L Latner; E Longstaff; K Pradhan
Journal:  Br J Cancer       Date:  1973-06       Impact factor: 7.640

10.  Anti-tumour activity of aprotinin.

Authors:  A L Latner; E Longstaff; G A Turner
Journal:  Br J Cancer       Date:  1974-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.